Noman, M., Ferrante, M., Bisschops, R., Hertogh, G. D., den Broeck, K. V., Rans, K., . . . Assche, G. V. (2017). Vedolizumab Induces Long-term Mucosal Healing in Patients With Crohn's Disease and Ulcerative Colitis. Journal of Crohn's & Colitis, 11(9), 1085. https://doi.org/10.1093/ecco-jcc/jjx048
Chicago Style (17th ed.) CitationNoman, Maja, Marc Ferrante, Raf Bisschops, Gert De Hertogh, Karolien Van den Broeck, Karen Rans, Paul Rutgeerts, Séverine Vermeire, and Gert Van Assche. "Vedolizumab Induces Long-term Mucosal Healing in Patients With Crohn's Disease and Ulcerative Colitis." Journal of Crohn's & Colitis 11, no. 9 (2017): 1085. https://doi.org/10.1093/ecco-jcc/jjx048.
MLA (9th ed.) CitationNoman, Maja, et al. "Vedolizumab Induces Long-term Mucosal Healing in Patients With Crohn's Disease and Ulcerative Colitis." Journal of Crohn's & Colitis, vol. 11, no. 9, 2017, p. 1085, https://doi.org/10.1093/ecco-jcc/jjx048.